» Authors » Catherine Dugast

Catherine Dugast

Explore the profile of Catherine Dugast including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 818
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hamadou W, Mani R, Bouali N, Besbes S, Bourdon V, El Abed R, et al.
Bull Cancer . 2021 Jun; 108(9):798-805. PMID: 34140154
Introduction: Apoptosis deregulation have been associated to tumorigenesis process and was highlighted as a prominent hallmark of cancer. Several mutations have been reported in several forms of Blood cancer. However,...
2.
Hamadou W, Mani R, Besbes S, Bourdon V, Ben Youssef Y, Eisinger F, et al.
Ann Hematol . 2017 Jul; 96(10):1635-1639. PMID: 28752392
The genetic predisposition to familial hematological malignancies has been previously reported highlighting inherited gene mutations. Several genes have been reported but genetic basis remains not well defined. In this study,...
3.
Hamadou W, Besbes S, Mani R, Bourdon V, Ben Youssef Y, Achour B, et al.
Bull Cancer . 2016 Nov; 104(2):123-127. PMID: 27866680
Introduction: Genetic predisposition to familial hematological malignancies was previously described through several epidemiological analyses, but the genetic basis remains unclear. The tumor-suppressor ARLTS1 gene was previously described in sporadic hematological...
4.
Jamard E, Volard B, Dugue A, Legros A, Leconte A, Clarisse B, et al.
Fam Cancer . 2016 Oct; 16(2):167-171. PMID: 27783335
Germline allele specific expression (ASE), resulting in a lowered expression of one of the BRCA1 alleles, has been described as a possible predisposition marker in Hereditary Breast or Ovarian Cancer...
5.
Hamadou W, Bourdon V, Letard S, Brenet F, Laarif S, Besbes S, et al.
Ann Hematol . 2016 Sep; 95(12):1943-1947. PMID: 27591990
Isocitrate dehydrogenase IDH 1 and IDH 2 mutations were reported in several cancer forms, especially in hematological malignancies, but were never been investigated in familial aggregation. The aim of this...
6.
Hamadou W, Bourdon V, Gaildrat P, Besbes S, Fabre A, Youssef Y, et al.
Ann Hematol . 2016 Apr; 95(7):1043-50. PMID: 27106701
Familial aggregation of hematological malignancies has been reported highlighting inherited genetic predisposition. In this study, we targeted four candidate genes: JAK2 and RUNX1 genes assuring a prominent function in hematological...
7.
Garcia A, Buisson M, Damiola F, Tessereau C, Barjhoux L, Verny-Pierre C, et al.
Eur J Hum Genet . 2016 Jan; 24(9):1324-9. PMID: 26785832
Although a wide number of breast cancer susceptibility alleles associated with various levels of risk have been identified to date, about 50% of the heritability is still missing. Although the...
8.
Sinilnikova O, Dondon M, Eon-Marchais S, Damiola F, Barjhoux L, Marcou M, et al.
BMC Cancer . 2016 Jan; 16:13. PMID: 26758370
Background: Less than 20% of familial breast cancer patients who undergo genetic testing for BRCA1 and BRCA2 carry a pathogenic mutation in one of these two genes. The GENESIS (GENE...
9.
Baert-Desurmont S, Charbonnier F, Houivet E, Ippolito L, Mauillon J, Bougeard M, et al.
Eur J Hum Genet . 2015 Apr; 24(1):99-105. PMID: 25873010
To determine if the at-risk single-nucleotide polymorphism (SNP) alleles for colorectal cancer (CRC) could contribute to clinical situations suggestive of an increased genetic risk for CRC, we performed a prospective...
10.
Ricordel C, Labalette-Tiercin M, Lespagnol A, Kerjouan M, Dugast C, Mosser J, et al.
Lung Cancer . 2014 Dec; 87(1):80-4. PMID: 25433984
We report two cases of non-smoker patients diagnosed with EGFR-mutated lung adenocarcinoma and bearing germinal TP53 gene mutation, also known as Li-Fraumeni syndrome (LFS). We describe for the first time...